معرفی
Pekka Rauhala serves as an Adjunct Professor (Docent) at the University of Helsinki's Faculty of Medicine, Department of Pharmacology within Medicum. He holds a Docent contract, acts as Supervisor in the Doctoral Programme in Drug Research, and maintains active visiting researcher status. His institutional presence spans decades with continuous research output from 1984 to 2025.
Rauhala's research centers on pain mechanisms and opioid pharmacology, with deep specialization in spinal cord neuropharmacology, opioid tolerance development, and glial cell interactions. His work integrates molecular neuroscience, metabolomics, and drug delivery systems to investigate polyneuropathy, intrathecal pharmacokinetics, and neuroinflammatory pathways in chronic pain models. Primary methodologies involve rat-based experimental systems examining gene expression, microglial activation, and lymphatic transport mechanisms.
Analysis of his 79 research outputs (including 15+ recent publications) reveals consistent focus on opioid-glial interfaces, with escalating emphasis on transcriptomic and metabolomic approaches since 2020. His publication trajectory demonstrates methodological evolution from classical pharmacokinetics toward multi-omics integration while maintaining core investigation of morphine tolerance mechanisms.
Rauhala actively supervises doctoral candidates within the Drug Research Programme and collaborates through two major projects: the ongoing "Glia and pain" initiative and the completed EC-FP7 GLORIA project (2013-2018) targeting glial-opioid receptor interfaces for chronic pain therapeutics. His work involves significant cross-institutional partnerships with researchers including Eija Kalso, Mikko Airavaara, and Tiina Lilius.
Based at Medicum's B211B facility (PO Box 63), he maintains dual email contacts and direct phone lines, reflecting ongoing laboratory engagement. His research group operates within Helsinki's pain neuroscience consortium, contributing to translational pain medicine through mechanistic studies of drug delivery systems and neuroimmune interactions.
